Althea Group Holdings Ltd. ( (AU:AGH) ) just unveiled an update.
Althea Group Holdings Ltd. has announced the sale of its pharmaceutical assets to Tasmanian Botanics Pty Ltd for $1 million, along with a revenue-sharing arrangement on residual inventory sales. This strategic divestment allows AGH to concentrate on the booming THC-infused beverage market in North America, leveraging its expertise and proprietary technology to capitalize on growing consumer demand. The transaction aligns with AGH’s vision to enhance shareholder value by focusing on high-growth, lower-risk product categories, and ensures continuity of care for Althea’s existing patients and prescribers.
More about Althea Group Holdings Ltd.
Althea Group Holdings Limited (ASX: AGH) is a global leader in the manufacturing, sales, and distribution of THC-infused beverages. The company focuses on the rapidly expanding market for these products, particularly in North America, where its subsidiaries Peak Canada and Peak USA are positioned as leaders. With cutting-edge facilities and proprietary technology, AGH is at the forefront of the industry’s transformation.
Average Trading Volume: 784,378
Technical Sentiment Signal: Sell
Current Market Cap: A$18.1M
See more insights into AGH stock on TipRanks’ Stock Analysis page.